Tag:

counsel

Health

INO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to take a leading role in the litigation.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its CELLECTRA device manufacturing and the timeline for submitting its INO-3107 Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA). Specifically, the claim is that the company lacked sufficient information to justify accelerated approval or priority review for INO-3107, and that its overall regulatory and commercial prospects were overstated.

Who is Rosen Law Firm?

Rosen Law Firm, a global investor rights law firm, is leading the charge in this case. They specialize in securities class actions and shareholder derivative litigation, representing investors worldwide. The firm highlights its track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and consistently ranking among the top firms in the field. They were ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

What Does This Mean for Investors?

If you purchased Inovio securities during the specified Class Period, you may be entitled to compensation without incurring out-of-pocket fees or costs, through a contingency fee arrangement. A lead plaintiff directs the litigation on behalf of other class members.

Navigating Securities Class Action Lawsuits: A Growing Trend

Securities class action lawsuits are becoming increasingly common, reflecting a heightened focus on corporate accountability and investor protection. These lawsuits often arise when companies are accused of misleading investors about their financial performance or business prospects. The Inovio case is part of this broader trend.

The Role of “Middlemen” Law Firms

Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record. They caution investors to be wary of firms that act merely as “middlemen,” referring clients to other firms that actually litigate the cases. This highlights a potential pitfall for investors seeking legal representation.

Contingency Fee Arrangements: How They Work

Contingency fee arrangements are standard in securities class action lawsuits. Which means investors do not pay legal fees upfront. Instead, the law firm receives a percentage of any recovery obtained through settlement or judgment. This arrangement makes legal representation accessible to a wider range of investors.

Key Dates and How to Participate

The crucial date to remember is April 7, 2026. Here’s the deadline for investors who wish to move the Court to serve as lead plaintiff. To join the Inovio class action, you can visit https://rosenlegal.com/submit-form/?case_id=52847, call Phillip Kim, Esq. Toll-free at 866-767-3653, or email [email protected].

FAQ

Q: What is a lead plaintiff?
A: A lead plaintiff is a representative party who directs the litigation on behalf of other class members.

Q: Do I have to be the lead plaintiff to benefit from the lawsuit?
A: No, an investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Q: What are the costs involved in joining the class action?
A: You may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

Q: Is a class already certified?
A: No, a class has not yet been certified. You are not represented by counsel unless you retain one.

Did you realize? Rosen Law Firm has recovered hundreds of millions of dollars for investors.

Follow Rosen Law Firm on LinkedIn, Twitter, and Facebook for updates.

Pro Tip: Carefully consider your options and consult with legal counsel before making any decisions regarding your participation in this class action.

To learn more about this case and your potential rights, visit Rosen Law Firm’s website or contact Phillip Kim, Esq. Directly.

0 comments
0 FacebookTwitterPinterestEmail
Health

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Class Action

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to participate in a securities class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set for those wishing to direct the litigation.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its business operations. Specifically, the claims center around issues with the manufacturing of the CELLECTRA device, delays in submitting the INO-3107 Biologics License Application (BLA) to the FDA, and overstated regulatory and commercial prospects for INO-3107. Investors reportedly suffered damages when these details came to light.

Key Allegations Detailed

  • Manufacturing Deficiencies: Concerns about the quality and reliability of the CELLECTRA device manufacturing process.
  • Delayed BLA Submission: Inovio was allegedly unlikely to submit its BLA for INO-3107 by the projected timeframe of the second half of 2024.
  • Questionable FDA Approval Path: Insufficient data to support accelerated or priority review by the FDA.
  • Overstated Prospects: An overly optimistic portrayal of the drug’s potential for regulatory success and market performance.

Rosen Law Firm Takes the Lead

Rosen Law Firm, a global investor rights law firm, is spearheading the class action. The firm encourages investors to select qualified counsel with a proven track record in securities litigation. They caution against firms that act merely as “middlemen,” referring cases to other firms without possessing the necessary expertise. Rosen Law Firm highlights its own success, including achieving the largest ever securities class action settlement against a Chinese Company and consistently ranking among the top firms in securities class action settlements.

The firm emphasizes its experience representing investors globally and its focus on securities class actions and shareholder derivative litigation. They have recovered hundreds of millions of dollars for investors, including over $438 million in 2019.

How to Participate and Important Considerations

If you purchased Inovio securities during the Class Period, you may be entitled to compensation without out-of-pocket fees through a contingency fee arrangement. To join the class action, you can:

If you wish to serve as lead plaintiff, you must file a motion with the Court by April 7, 2026. It’s important to note that a class has not yet been certified, and you are not automatically represented by counsel unless you retain one. You have the right to choose your own counsel or remain an absent class member.

The Rise of Securities Class Action Lawsuits

Securities class action lawsuits have become increasingly common in recent years, reflecting a growing awareness of investor rights and a more active legal landscape. These lawsuits often arise from allegations of corporate misconduct, such as misleading financial statements or inaccurate disclosures about product development. The potential for significant financial recovery makes these cases attractive to investors who believe they have been harmed by fraudulent or negligent behavior.

Did you know? The number of securities class action filings can fluctuate based on market conditions and regulatory enforcement activity. Periods of market volatility often see an increase in litigation.

FAQ

Q: What is a lead plaintiff?
A: A lead plaintiff is a representative party who directs the litigation on behalf of other class members.

Q: What is a contingency fee arrangement?
A: You only pay legal fees if the case is successful, and the fees are a percentage of the recovery.

Q: Do I have to be the lead plaintiff to receive compensation?
A: No, your ability to share in any potential recovery is not dependent on serving as lead plaintiff.

Q: What if I don’t want to participate?
A: You can remain an absent class member and do nothing at this time.

Pro Tip: Document all your Inovio Pharmaceuticals stock transactions during the Class Period. This information will be crucial if you decide to participate in the lawsuit.

Follow Rosen Law Firm for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
Health

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

by Chief Editor
written by Chief Editor

Inovio Pharmaceuticals Investors Face Deadline in Securities Fraud Lawsuit

Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to join a class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set, according to Rosen Law Firm, a global investor rights firm.

What’s at Stake? Allegations of Misleading Statements

The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its CELLECTRA device manufacturing and the potential approval timeline for its INO-3107 drug. Specifically, the claims center around concerns that:

  • Manufacturing processes for the CELLECTRA device were deficient.
  • The company was unlikely to submit a Biologics License Application (BLA) for INO-3107 to the FDA by the second half of 2024.
  • Inovio lacked sufficient data to support accelerated or priority review by the FDA.
  • The overall regulatory and commercial prospects of INO-3107 were overstated.

These alleged misrepresentations, if proven, could have led investors to suffer damages when the true details came to light.

Who is Rosen Law Firm and Why Should Investors Pay Attention?

Rosen Law Firm is actively soliciting investors to potentially serve as lead plaintiff in the case. The firm emphasizes its experience in securities class actions and shareholder derivative litigation, highlighting a track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and being ranked No. 1 by ISS Securities Class Action Services in 2017 for the number of settlements achieved. They caution investors to carefully select legal counsel, noting that some firms act as “middlemen” rather than directly litigating cases.

Understanding Class Action Lawsuits and Lead Plaintiffs

A class action lawsuit allows a group of investors who have suffered similar losses to collectively pursue legal action. The lead plaintiff represents the interests of all class members. If you wish to serve as lead plaintiff, you must file a motion with the Court no later than April 7, 2026.

How Can Investors Participate?

Investors who purchased Inovio securities during the specified Class Period can explore their options by:

It’s important to note that participation does not require out-of-pocket fees, as the firm operates on a contingency fee arrangement.

The Rise of Securities Class Action Lawsuits: A Growing Trend

Securities class action lawsuits have become increasingly common in recent years, reflecting heightened investor awareness and scrutiny of corporate disclosures. Several factors contribute to this trend:

  • Increased Market Volatility: Periods of market turbulence often expose vulnerabilities in company performance and lead to investor losses.
  • Complex Financial Instruments: The growing complexity of financial products can make it difficult for investors to fully understand the risks involved.
  • Regulatory Scrutiny: Increased regulatory oversight and enforcement actions can uncover instances of corporate misconduct.

Pro Tip:

Don’t delay if you believe you may have been affected by this lawsuit. The lead plaintiff deadline is a firm date, and missing it could impact your ability to participate in any potential recovery.

FAQ

Q: What is a “Class Period”?
A: The Class Period refers to the specific timeframe during which investors may have been harmed by the alleged misconduct. In this case, it’s October 10, 2023, to December 26, 2025.

Q: Do I need to hire my own lawyer?
A: No, you can remain an absent class member and do nothing at this time. Though, you have the option to select your own counsel if you prefer.

Q: Will I have to pay anything to join the lawsuit?
A: No, Rosen Law Firm operates on a contingency fee basis, meaning you will not pay any out-of-pocket fees or costs.

Q: What does it mean to be a “lead plaintiff”?
A: The lead plaintiff is the representative party who directs the litigation on behalf of all class members.

Q: Is there a guarantee of recovery?
A: No, there is no guarantee of recovery in any class action lawsuit. The outcome depends on the specific facts of the case and the evidence presented.

Follow Rosen Law Firm for updates on LinkedIn, Twitter, or Facebook.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
Tech

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm

by Chief Editor
written by Chief Editor

Richtech Robotics Lawsuit: What Investors Necessitate to Know

Rosen Law Firm is encouraging investors who purchased securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026, and January 29, 2026, to secure legal counsel. This follows the filing of a securities class action lawsuit alleging false and misleading statements made by the company.

The Allegations: Misleading Claims About Microsoft Collaboration

The lawsuit centers around claims that Richtech Robotics falsely stated it had a collaborative and commercial relationship with Microsoft. According to the filing, this alleged misrepresentation impacted the company’s reported business operations and future prospects. Investors are claiming that when the truth emerged, they suffered financial damages.

Understanding Securities Class Action Lawsuits

Securities class action lawsuits are a legal mechanism allowing a group of investors to collectively seek compensation for losses resulting from fraudulent or misleading corporate practices. These cases often involve allegations of false statements in financial reports or public communications.

Key Dates and Deadlines for Investors

A crucial date for potential plaintiffs is April 3, 2026. What we have is the deadline to move the Court to serve as lead plaintiff in the class action. A lead plaintiff directs the litigation on behalf of other class members.

Why Choose Experienced Counsel? Rosen Law Firm’s Track Record

Rosen Law Firm emphasizes the importance of selecting qualified legal representation with a proven track record in securities litigation. The firm highlights concerns about firms that act as “middlemen,” simply referring cases to other attorneys. Rosen Law Firm boasts a history of success, including achieving the largest ever securities class action settlement against a Chinese Company, and consistently ranking among the top firms in securities class action settlements. In 2019, the firm secured over $438 million for investors, and founding partner Laurence Rosen was named a Titan of Plaintiffs’ Bar in 2020.

How to Join the Richtech Robotics Class Action

Investors who purchased Richtech Robotics securities during the specified Class Period may be eligible for compensation without upfront costs through a contingency fee arrangement. To learn more or join the class action, investors can visit https://rosenlegal.com/submit-form/?case_id=51742, call Phillip Kim, Esq. Toll-free at 866-767-3653, or email [email protected].

What Happens Next? The Litigation Process

The legal process involves several stages, including discovery, where evidence is gathered, and potential settlement negotiations. It’s important to remember that no class has been certified yet. Until certification, investors are not automatically represented by counsel and can choose their own legal representation.

FAQ: Richtech Robotics Securities Litigation

  • What is the Class Period? The Class Period is between January 27, 2026 and 12:00 PM ET on January 29, 2026.
  • What is a lead plaintiff? A lead plaintiff is a representative party who directs the litigation on behalf of other class members.
  • Is there a cost to join the lawsuit? No, the firm operates on a contingency fee basis, meaning there are no upfront costs.
  • Do I have to be the lead plaintiff to receive compensation? No, an investor’s ability to share in any potential recovery is not dependent on serving as lead plaintiff.

Pro Tip: Document all your Richtech Robotics stock transactions during the Class Period. This documentation will be crucial if you decide to participate in the lawsuit.

Stay informed about this case and other investor rights issues by following Rosen Law Firm on LinkedIn, Twitter, and Facebook.

Attorney Advertising. Prior results do not guarantee a similar outcome.

0 comments
0 FacebookTwitterPinterestEmail
News

LA Council OKs $1.8 Million More for Outside Counsel in Homeless Settlement

by Rachel Morgan News Editor
written by Rachel Morgan News Editor

The Los Angeles City Council on Wednesday authorized an additional $1.8 million to cover outside legal fees related to ongoing litigation stemming from a settlement concerning the city’s response to homelessness.

Legal Costs Continue to Rise

The council voted 9-4 to approve City Attorney Hydee Feldstein Soto’s request for increased funding for the law firm Gibson Dunn & Crutcher LLP. The decision followed a two-hour closed-door discussion. The $1.8 million will be drawn from a previously approved $5 million allocation for the contract.

Did You Know? The initial contract with Gibson Dunn & Crutcher LLP in May 2025 began at $900,000.

Council members John Lee, Tim McOsker, Imelda Padilla, and Monica Rodriguez opposed the funding increase. Council members Nithya Raman and Curren Price were absent during the vote. Ivor Pine, a spokesman for Feldstein Soto, stated that “the best interests of the city are served by continuing to work with Gibson, a firm that has exceeded expectations and delivered exceptional results for the city.”

Background of the Litigation

The lawsuit originated in 2020 when the LA Alliance for Human Rights, comprised of business owners and residents, sued the city and county of Los Angeles. The plaintiffs sought to compel greater efforts to shelter the city’s homeless population. A settlement was reached in 2022, overseen by U.S. District Judge David Carter.

However, last summer, Judge Carter determined the city had not met its obligations under the settlement agreement. The agreement mandates the creation of 12,915 shelter beds and the removal of 9,800 encampments by June 2027. As of recent court filings, over 3,800 beds still need to be established.

Expert Insight: The escalating legal costs reflect the complexity of addressing homelessness and the challenges of implementing court-ordered solutions. The city’s apparent difficulty in meeting the terms of the settlement suggests a fundamental tension between the goals of the agreement and the practical realities of providing shelter and services.

Judge Carter, in his order, noted the city’s “consistent lack of cooperation and responsiveness — an unwillingness to provide documentation unless compelled by court order or media scrutiny.” While stopping short of declaring a full breach of the agreement or appointing a receiver, the judge did install a federal monitor to oversee the city’s compliance. In January, the city was ordered to pay over $1.8 million in attorneys’ fees and costs to the Alliance and related groups, a decision the city is currently appealing.

To date, the contract with Gibson Dunn & Crutcher LLP has grown to nearly $7.5 million with Wednesday’s approval. The firm billed the city $1.8 million for approximately two weeks of work, with attorneys charging up to $1,295 per hour. By August 2025, the firm had billed an additional $3.2 million.

Frequently Asked Questions

What is the LA Alliance for Human Rights?

The LA Alliance for Human Rights is a group of business owners and residents who sued the city and county of Los Angeles in 2020 to ensure more homeless people were sheltered.

What did Judge Carter determine last summer?

Last summer, Judge Carter determined the city failed to meet its obligations under the 2022 settlement agreement regarding the creation of shelter beds and removal of encampments.

What is the current status of the city’s appeal?

Attorneys representing the city appealed Judge Carter’s January decision ordering Los Angeles to pay over $1.8 million in attorneys’ fees and costs to the Alliance and other groups.

As the city continues to navigate this complex legal battle, it remains to be seen whether the increased legal representation will be sufficient to achieve compliance with the settlement agreement and address the ongoing homelessness crisis.

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Mastering Chinese Language Skills While Pursuing Career Opportunities: Insights from Rich Sonjajang at Pearl Intersection

by Chief Editor
written by Chief Editor

Exploring Future Trends in Restaurant Recruitment

The Evolution of Culinary Careers

In recent years, the culinary world has witnessed a transformative shift, with more individuals seeking diverse career paths within the industry. For instance, kitchen assistance roles, once seen as mere stepping stones, are now recognized for their specialized skillsets and potential career advancements, particularly in niche sectors such as Japanese and sashimi restaurants.

According to a 2024 report by the Dining and Culinary Association (DCA), 65% of new recruits in this sector value roles that promise structured learning and growth over time, reflecting a paradigm shift towards skill development.

Digital Platforms in Recruitment

Technology is playing a pivotal role in modern recruitment strategies. Digital platforms and social media channels are increasingly leveraged to attract culinary talent, making the recruitment process more dynamic and accessible. For example, platforms like KCrWork are revolutionizing how candidates and employers connect, encouraging interaction and streamlining the recruitment process.

In 2023 alone, 75% of cookery-related job applications were facilitated through digital means, demonstrating the growing importance of online recruitment tools.

Work-Life Balance in Culinary Careers

As societal values evolve, so too does the emphasis on work-life balance within the culinary industry. More businesses are adopting flexible working conditions, including negotiated work hours and on-site wellness initiatives, to attract and retain top talent. For instance, establishments such as Sacheon Namyang Branch provide tailored work hours consultation, accommodating the needs of both the business and its employees.

Emerging Skill Gaps and Educational Demand

The demand for specialized skills, such as those in international cuisine and advanced culinary techniques, is rapidly growing, leading to a noticeable skill gap within the industry. Educational institutions and online learning modules are responding by offering tailored programs that address these specific skill requirements.

In 2025, it is projected that over 50% of culinary programs will integrate vocational training for emerging cuisines, highlighting the industry’s adaptive nature.

Addressing Inclusivity and Diversity

Inclusive practices are becoming integral to recruitment strategies in the culinary arts, encouraging a diverse and representative workforce. Companies are championing inclusivity by removing unwarranted barriers such as irrelevant educational or career backgrounds to ensure a more equitable opportunity landscape for all aspiring chefs and kitchen staff.

FAQs

What are some emerging roles in the culinary industry?

Emerging roles include specialized positions like sushi chefs, food technicians, and culinary content creators, with an emphasis on creativity and experiential dining.

How do digital recruitment platforms benefit candidates?

They offer greater accessibility and flexibility, allowing candidates to explore a broader range of opportunities seamlessly from anywhere.

Interactive Elements

Pro Tip: Consider internships or apprenticeships to gain hands-on experience in niche culinary areas, such as Japanese cuisine or craft brewing.

Call to Action

Are you eager to explore more about culinary careers or the future of food service? Comment below with your thoughts or subscribe to our newsletter for the latest insights and trends. Don’t miss this opportunity to enrich your culinary journey!

0 comments
0 FacebookTwitterPinterestEmail